Cost-Benefit Decisions Will Reside With Docs/Patients, Not CMS – McClellan

CMS will continue to refrain from incorporating cost-effectiveness analyses into coverage decisions, Administrator Mark McClellan affirmed May 18

More from Archive

More from Medtech Insight